Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd
SSE:688505
Intrinsic Value
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd is a CN-based company operating in Pharmaceuticals industry. [ Read More ]
The intrinsic value of one Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd stock under the Base Case scenario is 26.25 CNY. Compared to the current market price of 7.27 CNY, Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd is Undervalued by 72%.
Valuation Backtest
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd
Run backtest to discover the historical profit from buying and selling Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd
| Current Assets | 1.9B |
| Cash & Short-Term Investments | 1.2B |
| Receivables | 625.1m |
| Other Current Assets | 48.5m |
| Non-Current Assets | 1B |
| Long-Term Investments | 287.5m |
| PP&E | 520.2m |
| Intangibles | 86.4m |
| Other Non-Current Assets | 113.2m |
| Current Liabilities | 505m |
| Accounts Payable | 8.1m |
| Accrued Liabilities | 366.3m |
| Other Current Liabilities | 130.7m |
| Non-Current Liabilities | 14.1m |
| Long-Term Debt | 11m |
| Other Non-Current Liabilities | 3.2m |
Earnings Waterfall
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd
|
Revenue
|
850.7m
CNY
|
|
Cost of Revenue
|
-74.1m
CNY
|
|
Gross Profit
|
776.7m
CNY
|
|
Operating Expenses
|
-674.3m
CNY
|
|
Operating Income
|
102.3m
CNY
|
|
Other Expenses
|
6.3m
CNY
|
|
Net Income
|
108.6m
CNY
|
Free Cash Flow Analysis
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd
Profitability Score
Profitability Due Diligence
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd's profitability score is 52/100. The higher the profitability score, the more profitable the company is.
Score
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd's profitability score is 52/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd's solvency score is 74/100. The higher the solvency score, the more solvent the company is.
Score
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd's solvency score is 74/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd
Shareholder Return
Price
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd
| Average Annual Return | -37.01% |
| Standard Deviation of Annual Returns | 16.67% |
| Max Drawdown | -84% |
| Market Capitalization | 538.7m CNY |
| Shares Outstanding | 74 093 985 |
| Percentage of Shares Shorted |
N/A
|
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd is a CN-based company operating in Pharmaceuticals industry. The company is headquartered in Shanghai, Shanghai and currently employs 776 full-time employees. The company went IPO on 2002-08-13. Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd is a China-based company mainly engaged in research and development, manufacturing and marketing of biomedicine. The firm's products include aminolevulinic acid hydrochloride topical powder (trade name: ALA) and hemporfin or injection (trade name: FuMeiDa), and doxorubicin hydrochloride liposome injection (trade name: LIBOd), among others. Its products are mainly used for skin venereal disease treatment and anti-tumor treatment. The firm conducts its businesses in the domestic market.
Contact
IPO
Employees
Officers
The intrinsic value of one Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd stock under the Base Case scenario is 26.25 CNY.
Compared to the current market price of 7.27 CNY, Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd is Undervalued by 72%.
You don't have any saved screeners yet
